Why is Ind-Swift Labs. falling/rising?

As of 04-Jul, Ind-Swift Laboratories Ltd is currently priced at 114.25, with no change in price (0.00%). The stock has shown a performance of +3.97% over the past week and +19.77% over the past month, indicating a positive short-term trend. However, it has underperformed its sector by -0.51% today. The stock is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bullish trend. Additionally, there has been a significant increase in investor participation, with delivery volume rising by 60.11% against the 5-day average. Despite a year-to-date return of +4.15%, the stock has faced challenges, including a -10.11% return over the past year and negative results in the last three quarters, which have contributed to concerns about its long-term fundamental strength.
Broader market context indicates that while the stock has outperformed the Sensex by +3.97% over the past week, it has lagged behind the broader market over the past year, where the BSE500 has generated returns of +2.13%. The company has seen an increase in institutional investor participation, which may provide some support; however, the high Debt to EBITDA ratio and declining net sales raise red flags about its financial health. The stock's attractive valuation metrics, such as a Price to Book Value of 0.7 and a return on equity of 10%, suggest some potential for recovery, but the recent negative performance and lack of declared results in the last six months create uncertainty for investors.